Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the Unipol nine months 2026 results conference call. As a reminder, all participants are in listen-only mode. After the presentation, there will be an opportunity to ask questions. At this time, I would like to turn the conference over to Mr. Matteo Laterza, CEO of Unipol. Please go ahead, sir.
Thank you very much, and thank you to all of you for joining this meeting. As usual, let me share with you a few thoughts on the result before I open the floor to your questions. As you know, the third quarter of the year is usually seasonally weaker, mainly because of NatCat events. On this front, this year was not as favorable as 2025. This was mostly due to some event regarding Northern Italy between the late August and the beginning of September. On the investment side, the third quarter also saw a significant rise in interest rate, as you know very well, and a widening of the spread, especially on the government bond side, and this weighted in part on our solvency position. Despite all these events, we are closing a very solid quarter, on my point of view.
On one side, we saw a very good premium growth across the board, both in life and in P&C. Secondly, we had an improvement in the combined ratio. As you have seen in the presentation, we closed the combined ratio at 92.5%, in line with the target of our industrial plan, notwithstanding the higher impact coming from NatCat event. I have to say that we are starting to see the result of all the action that we implemented in the past three years in terms of de-risking, reducing risk in some area of the country, repricing a significant part of the risk, and the consequence of this, we had an impact, but this impact has been much lower than it would have been if we had not implemented this kind of action.
We saw a very good result also in life profitability, very good contribution coming from the main line of business, principally traditional products, but also term premium and also unit-linked, in which we did and we performed a very significant increase in production compared to the numbers of 2025. Finally, strong support coming from investment income, very impactful. There is, as you know, also the contribution coming from our investment in SpaceX that can be quantified in EUR 170 million globally, but also without the contribution of this particular investment, the contribution coming from investment has been significant. I can therefore say that overall, the group is firmly on track to achieve all the targets of our industrial plan regarding, of course, 2026. Having said this, with Enrico San Pietro, as usual, we are open to answer to your question. Thank you very much.
This is the Chorus Call conference operator. We will now begin the question and answer session. Anyone who wishes to ask a question may press star and one on their touchtone telephone. To remove yourself from the question queue, please press star and two. Please pick up the receiver when asking questions. Anyone who has a question may press star and one at this time. The first question is from Tommaso Nieddu with Kepler Cheuvreux. Please go ahead.
Hello, and thank you a lot for taking my questions. I have three, please. The first one is on technical profitability. You reported a very strong combined ratio of 92.5% despite NatCat and large losses, which were, I think, above market expectations. At the same time, the attritional loss ratio was particularly strong. Could you help us understand how much of this reflects better underlying claims experience versus the prudence you have been applying to initial loss picks? The second question is on solvency. The group ratio declined by 15 percentage points quarter- on- quarter, and also despite strong insurance earnings. Could you provide a bridge of the main moving parts, particularly organic capital generation variances, any changes in the SCR?
Also because, given the widening in the sovereign spreads during the quarter, it would be great if you could clarify the impact of the volatility adjustment. I would have expected some positive offset on the liability side, so it would be helpful to understand the net sensitivity to spread movement, so much of the decline was driven by other factors. The third one on the running yield, which has increased from last year, and the 4.7 is particularly impressive given the environment. Could you provide some color on the reinvestment yields versus the portfolio running yield and how much of further improvement you expect? Thank you.
Thank you to you. I will answer the final two questions, then I will leave the floor to Enrico regarding the technical profitability. First of all, in solvency, as I said before, we had a negative contribution coming from economic variance. That means the impact regarding the trend of financial market that we can be quantified in 6 percentage points. The increase of interest rate, the widening of the spread in the credit market, equity did not move very much in the third quarter, so they didn't give a significant negative contribution. But combining interest rate and the credit spread, the negative impact on the solvency was in the whereabouts of 6 percentage points.
On top of that, we have to add a contribution negative of non-economic variance that is not related to the trend of financial market, that is mainly due to the change in the asset allocation that we implemented during the quarter. You know, because we announced with the press release that in June, we set a contract of total return equity swap on BPER Banca that we started to execute during the third quarter. At the end of the third quarter, we finalized the contract with the total amount of shares close to 5% of the bank. This is an increase in our equity weight exposure of EUR 1.5 billion, and consequently gave an impact that can be quantified in 5 percentage points, more or less, regarding the increase of asset allocation.
If we would not have invested, of course, in this financial instrument that is very important for us in order to execute our increase in the equities weight in BPER, the solvency would have been higher than the 244%. This is it. So, part of the decrease, 6 percentage points, can be considered a sort of impact coming from financial market that is completely in line with the sensitivity that we provide every time regarding how our solvency ratio can change depending on the increase of the credit spread or equity or Italian government bond. 5 percentage points are due to the asset allocation, and in particular, to the execution of the total return equity swap on BPER.
There has not been a change, I think only 1 basis point of increase in the volatility adjustment, and so consequently, no positive contribution has come from the increase of the volatility adjustment. Regarding the running yield, the running yield is the contribution coming from coupon and dividends, of course. Dividend in 2026 has been quite supportive for our investments. The increase of interest rate that we have seen in the third quarter and that we expect to continue in the next few quarter will support the reinvestment yield that we can execute within the end of the year, and mainly in 2027. I can say that I'm quite confident that in P&C, we can reinvest the coupon and dividend in a range of yield that is between 4.5 and 5.
In life, where the duration is longer, we can expect also the possibility to get something more than that. Of course, assuming that interest rate will remain at the same level in which they are today. On the first question, I leave Enrico to comment on.
Thank you, Matteo. Good morning, Tommaso. Technical profitability improved in several ways. We had an improvement of the attritional loss ratio, especially in motor, an improvement in the prior year reserve development, and also an improvement in the discount effect. The total effect of all these are around 4% improvement, and this was able that more than offset the 2.8% worsening related to NatCat events.
Okay, thank you.
The next question comes from Michael Huttner with Berenberg. Please go ahead.
Hi there. Thank you so much for taking my questions. I had three. The first one is on the high NatCat ratio, the 18%. I just wondered, in the quarter, that's my estimate, I just wondered how we should think about that. I think the January number was 8%, so it's high. Also, I don't think you reach aggregate cover, so I'm wondering whether you've changed your policy on reinsurance. The second is a very strong growth in health, the 8% in nine months. I think Q3 standalone must be close to 19%. Is this set to continue? Is this a bit of a one-off? That's it. Thank you.
Hi, Michael. About NatCat events, yeah, of course, 2026 was not a good year for the Italian market. As Matteo told us, we have been de-risking, especially for hail, for severe convective storms after 2023. So now we have a probabilistic risk measure that is around 20% lower than three years ago. This is helping us to suffer less about these kind of events. Now we are basically at the amount of expected losses we put in our budget, and we are quite close, but not yet to the level in which our insurance treaties could begin to work. Both the main XL treaty and the aggregate are not working, and we hope they will not be working because, of course, the year end should be quiet. Second question about health. Yeah, we reported strong growth. It is not unusual.
We have been growing double digit or high single digit for years. The market is growing. We had, during this year, a period in which growth was lower, but we told you that things could be better. This is happening for several reasons. Retail production of banking and also agent channel, but also corporate business in which we had the addition of big contracts on the employees of the Ministry of Education of Italy.
Brilliant. Thank you very much.
The next question comes from Andrea Lisi with Equita. Please go ahead.
Good morning. Thank you for taking my questions. The first one is clearly more a kind of guess because we did not have the final version yet, but if you can provide us some color, some idea of the impact you expect from the measures currently envisaged by the draft of the budget law as it is today. The second question is related to the fact that in the plan and also last year, you have expensed the integration charges related mainly to staff turnover. I want to ask you when we should expect them and if it is possible to provide an indication of the amount. The other question is on the CSM release in the third quarter that is a bit down, and if you can update us on what are your expectations in going on. Thank you.
Regarding the financial law, the answer is quite articulated because there are several items that can impact on our numbers in the next few years, but also in 2026. First of all, the additional IRES component for the insurance industry, based on the information that we have today, can have a potential impact of EUR 30 million in 2027 and 2028, based on what we expect will be the pre-tax profit that we expect to deliver in the next couple of years. There is another item regarding the decrease in tax deductibility from 90% to 30% for IRAP purposes of other administrative expenses and depreciation, where we expect to have, again, next year, an impact of almost EUR 20 million.
Then there is the postponement of the deductibility of both negative items in which have allowed the company to record the DTA, where the measure is expected to be overall in the whereabouts of EUR 30 million in 2027 and EUR 40 million in 2028. Overall, combining all these things that I said, the total impact is expected to be between EUR 80 million and EUR 90 million next year, 2027. Then there is the measure regarding the restructuring of the use of the Superbonus tax credit, where the amount that can be deducted in 2027 are expected to be split in 10 years, where you have to provision the total amount of credit that will be paid in 2027, and we expect this to have a potential negative contribution in 2026 of more or less EUR 50 million.
This is the information that I have based on what are the information that we have today. You know that the discussion in the lower house is still at the beginning of the process, so we will see which will be the final result of the budget law. These are the numbers based on the information that I have. The second question is related to the provision on the charge on the staff turnover that is not included in the third quarter of 2026 and will be included in the final quarter of this year. We expect more or less the same amount that we put last year, so in the whereabouts between EUR 70 million and EUR 80 million.
On CSM release in the third quarter, I have to say that regarding and looking at the CSM that we produced in the quarter and what we released, there is a sort of equilibrium. We cannot expect to produce always a larger amount than what we release. It depends on the quality of the production and in terms of new production, of course, and the effect of the value in force on the portfolio. Secondly, we had this time a negative contribution coming from economic variance for the first time since this year, and this contributed to reduce the total amount of the CSM. I am not surprised to see an opening CSM that is higher than the number at which we close, mainly due to the negative contribution coming from the economic variance.
Thank you.
The next question comes from Antonio Gianfrancesco with Intermonte. Please go ahead.
Good morning, and thank you for taking my questions. I have three. The first one is on the deal with Intesa and Monte dei Paschi. I was wondering how you are thinking about the valuation of Monte dei Paschi carve-out when it will be contributed to BPER, because you are acquiring it from Intesa for something like EUR 3.5 billion, so roughly 8.5 PE. Clearly, at the end of time, the final valuation will determine your final ownership in the combined bank. So, what do you think about the valuation of this carve-out in the merger with BPER? The second one is on the transaction timing, because BPER recently mentioned that the potential closing of the merger could be around the first or second quarter of 2028. I was wondering whether this is also consistent with your expectations.
The third one is a follow-up on the BPER derivatives, because now you have received the authorization to increase your direct stake. I was wondering whether you are considering a physical settlement ahead of merger transaction with Monte dei Paschi, and what the potential cost associated with this physical settlement. The very last one, sorry about that, on life, because we saw a very strong premium growth, particularly in the unit-linked. I was wondering how you are seeing the performance of the existing BPER distribution network, particularly in terms of productivity and product mix, and whether you see room for faster acceleration even before the MPS transaction. Thank you.
Thank you to you. Regarding the transaction on Monte dei Paschi, it is quite early to discuss about the valuation at which we will execute the integration with BPER. As you correctly said, this is a transaction that we can expect to execute in 2028. There will be very different conditions regarding the valuation of the asset that we will buy from Intesa Sanpaolo, Monte dei Paschi di Siena. We will set the condition of the integration once we will have the full ownership of Monte dei Paschi. So it is very early. We did not start to discuss this with BPER, and I think that we will have time to do it in the next few quarters, mainly for sure starting from next year.
Regarding the derivative, yes, we obtained the authorization, as you know, to exceed the 20% stake in BPER and to have the de facto control on the bank. We already have the shares in terms of derivative. We only have to decide when to convert. Again, we have time to do it. For sure, we will do it before the general shareholder meeting of April, so we will decide when will be the right time to convert the derivative in physical. On bancassurance, I said in my introduction that the performance of unit-linked has been very good, more than EUR 300 million versus a little bit more than EUR 50 million in 2025.
I think that there is a great potential in bancassurance distribution network in BPER, and also once we will succeed in combining Monte dei Paschi in BPER, there is a lot of room to increase the productivity of the distribution network, not only in bancassurance, of course, but for us, bancassurance is very important. A part of the revenue synergies that we identified in the 800 overall million, 500 cost and EUR 300 million in revenue.
In the EUR 300 million of revenue, there is also the possibility to increase the commission for the bank coming from an increase in productivity in bancassurance. That is a very positive contribution for the bank, but also for our group, because there is another part of the synergies that is not in the bank, but is in the insurance company that regard the technical profitability coming from the increase of productivity that we can get from bancassurance. I am quite confident that we can do much better than this because there is a lot of potential in both the distribution network, both BPER and I think also Monte dei Paschi, both in P&C and in Life.
Okay, thank you. Just a clarification. Could you give us some more color about the potential cost associated with the physical settlement of BPER derivatives that for sure will depend on timing which we decide to do that, but to have an idea. Thank you.
No, there is not a cost. We have just to convert the shares in physical. Of course, there is a price at which we bought the shares that are the average of the third quarter in terms of BPER share price. You can do the math by yourself.
Okay, very clear.
Just to give a clarification on the answer that I gave on the impact of the financial law. When I mentioned EUR 85 million, it is a mix between economic and financial contribution on the numbers. It is not only 100% economic.
Okay. Thank you very much.
The next question comes from Alessia Magni with Barclays. Please go ahead.
Hi, good morning. Two questions, please. One is on dividend expectations. If you can help us to frame what we should expect, because should we think in terms of payout ratio or in absolute terms? I know you gave the EUR 930 million for full year 2026, but now given the strong year you had and the excess capital you are sitting on, it seems quite a low base. The other question is on if you can share where are you in the divestment process of SpaceX? Thank you.
Thank you to you. You know that what you define excess capital is necessary for us to finance the acquisition of Monte dei Paschi. It doesn't mean that we can distribute all the excess capital. I think that we are confident with the EUR 930 million of dividend that consider, as you know, also the payment of the dividend of the new shares that we issued on the rights issue that we executed last month. I think that it is a very good number. Having said that, we also gave to you the net profit that we expect to deliver once we have completed the transaction of Montepaschi and the integration in BPER. With the potential synergies that we identified in EUR 800 million, we expect in 2030 to have a total net profit of EUR 2 billion, as we said at the beginning of June in our presentation.
You can do your math in order to expect which can be the dividend payment that we can provide in perpetuity, assuming that EUR 2 billion is a number that we can deliver on all the financial conglomerate, insurance, and banking. On SpaceX, we have almost completed the divestment on the stock, in the sense that today we locked EUR 150 million of gain, and we still have something close to EUR 20 million that is still related to the price change of the stock price. We are quite completed the investment. We are close to 85% of the total amount sold in the market.
The next question comes from Elena Perini with Intesa Sanpaolo. Please go ahead.
Yes. Good afternoon, and thank you for taking my questions. I have got two questions. The first one is about your good result in terms of health combined ratio, if you can elaborate on this, as it is one of the strategic pillars, the health segment of your plan. The second question is a more general one. In the first half of September, there were some days in which insurance stocks were under pressure due to fears about AI potential disruption on the business. If you can elaborate a bit on this too. Thank you very much.
On AI, I can tell you, Elena, then Enrico is much more skilled on this topic. For us, it is an opportunity, and the opportunity is to implement this new technology in order to improve our effectiveness in distribution of our products. Italian market is a market where the distribution network of agents is still very strong. Clients need the contact with the agent, and the agent as human being, not the agent as AI operator. Consequently, I do not think this industry can transform itself very radically and rapidly, becoming a big threat for the so-called traditional operator. It is true that we cannot remain as traditional as we are today.
We have to change our business model in order to introduce more and more these kind of technologies in order to, not so much to reduce our cost base, because it is not the case, but we have to use this new technology in order to improve our productivity. This is what we are doing, and we will continue to do in the next few years in order to become an operator that succeed in using AI in order to give our client a set of products and a set of service that is in line with their needs. I disagree with the trend that you mentioned, that the operator that sold massively stocks belonging to the industry, insurance industry, because I don't think that AI has to be perceived as a threat. But I leave the floor to Enrico that is much smarter than me on this.
Hi, Elena. I'm going on with the second question about AI. Yes, I completely agree with Matteo. If I can add something, I think that our industry, the insurance industry, is one of the industries in which AI can bring the higher benefits. But I don't see, like others, like some of the analysts you mentioned, that this could mean that some newcomer can disrupt the business, but instead that traditional players like Unipol could improve significantly their efficiency, but also their ability to generate value with growth. I see much more as an opportunity the evolution of AI than a threat. Coming from the first question about health. Like I said a few minutes ago, we had several improvement in our activity and also in health. There is a continuous improvement on pricing, revising condition where it's needed, improving in claim settlement processes.
You can see also in health that was an improvement in the attritional loss ratio. There was an improvement in the discount ratio. There was an improvement in the prior year reserve development, and also in the acquisition ratio. Adding up more or less is 4 percentage points, but in health, there are no NatCat events, so the improvement is more visible.
The next question is a follow-up from Michael Huttner with Berenberg. Please go ahead.
Thank you so much for this opportunity. Could you talk please a little bit about the balance between pricing and motor, what the pressures are? Inflation costs, which obviously is negative, and also if there is also an offset from frequency and how you see that developing. Thank you.
Hi, Michael. The Italian market in motor third-party liability is in a soft period, so the increase in prices is slowing down. The last available data on the market is 1.6% growth of the average premium at the year end. So basically, we are in this market environment. Our increase of the average premium is slowing down, is now compared to the year before slightly over 1%. At the same time, we are experiencing an increase in the average cost of the claim that is more or less at the same level of the general inflation. The good thing that allow us to keep the loss ratio stable is a further decrease in loss frequency. It is not a massive one, but big enough to offset the average cost of the claim. So basically, motor third-party liability is stable.
Motor other damages, of course, suffer from NatCat events, so it is a little bit worse. But we can see a market condition that is stable in which we are able to keep our portfolio to have also some limited growth, and at the same time being able to keep our combined ratio healthy.
May I just ask, please, a little cheeky, a very quick follow-up on the NatCat. It was yesterday, the CFO of Zurich explained that in Switzerland, large hail events now every two years, and the pricing assumes every five or every seven years. I worked out from your numbers, but of course, my number is completely wrong, so ignore them, but that a big hailstorm now in Italy would cost probably the market about just under EUR 1 billion, which is a big number. So, I just wondered, do you see a change, or am I making things up?
Oh, yes, of course. If you mean that climate change is driving more and more NatCat events, that is for sure. That is why we are continuously improving our ability to price this kind of risk using a probabilistic approach that is consistent also with the calculation of our SCR, and of course, our insurance cover. Basically, we are expecting this kind of events, pricing accordingly, and also budgeting accordingly. Basically, also in a year that is not good at all, we will be quite close to the budget we fixed at the beginning of the year as far as NatCat events are concerned.
Brilliant. Thank you.
As a reminder, if you wish to register for a question, please press star and one on your telephone. For any further questions, please press star and one on your telephone. Gentlemen, there are no more questions registered at this time.
Okay, thank you very much to all of you for participating to this call, and we will meet again to discuss the final result of 2026 in February of next year. Thank you very much.
Ladies and gentlemen, thank you for joining. The conference is now over. You may disconnect your telephones. Thank you.